カテゴリー： 世界, 医療/バイオ, Grand View Research

組織工学の世界市場2023-2030：市場規模、シェア、動向分析

【英語タイトル】Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, Orthopedics, Musculoskeletal & Spine, Dental, Urology, Cardiology & Vascular), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23OCT017）・商品コード：GRV23OCT017
・発行会社（調査会社）：Grand View Research
・発行日：2023年8月
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

組織工学市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の組織工学市場規模は2030年までに431億3000万米ドルに達し、2023年から2030年までの推定CAGRは14.28%で成長すると推定されています。心血管疾患、糖尿病、整形外科疾患などの慢性疾患の増加により、損傷した組織を修復または置換する組織工学ソリューションの需要が高まっています。生体材料、3Dバイオプリンティング、幹細胞研究、遺伝子編集技術の進歩が組織工学の分野を推進し、複雑で機能的な組織の開発を可能にしています。

同種組織移植法は、自家移植の使用や利用しやすさに関連する課題や限界に効果的に対処するものです。さらに、同種インプラントを生体インプラントに変換することを目的とした、インプラントの固定や滅菌などの特殊な処置の進歩が、この市場の収益を押し上げると予想されています。

組織再生技術は、その効果的な製品と低い拒絶率により人気を集めており、再生治療の増加に繋がっています。現在、前臨床研究では、心臓血管外科手術や治療における組織工学的人工血管の使用に焦点が当てられています。さらに、組織工学的膀胱は現在、患者の体外への移植に成功しています。こうした進歩にもかかわらず、市場の成長を妨げているのは、製品開発コストの高さや、幹細胞研究や組織工学製品を取り巻く倫理的懸念といった課題です。

組織工学市場のレポートハイライト

- 用途別では、筋骨格系疾患の有病率が上昇していることから、整形外科、筋骨格系、脊椎分野が2022年に59.76%の最大売上シェアを占めました。組織工学は、若いアスリートの半月板の欠損から肩甲上腕関節の骨軟骨の異常まで、いくつかの筋骨格系障害の管理における整形外科医の重要な治療オプションとして浮上しています。

- 循環器・血管分野は、世界的な心血管障害の急増により、予測期間中に25.94%のCAGRで急成長すると予測されています。

- 過去20年間、心臓細胞療法または心筋形成術は、再生による心臓疾患の管理を目的とした研究の大部分で重要な焦点となっています。

- 単一心室奇形を含む先天性奇形を持つ小児の増加により、心臓移植の需要が高まっています。

- 地域別では、北米が2022年に51.23%と最大の売上シェアを占めています。これは、幹細胞治療に対する意識の高まりと、高齢者人口の増加によるものです。

- アジア太平洋地域は、中国とインドの新興経済圏に未開拓のビジネスチャンスが存在するため、予測期間中に15.84%のCAGRで最速の成長が見込まれています。

第1章. 方法・範囲
第2章. エグゼクティブサマリー
第3章. 組織工学市場変動・動向・範囲
第4章. 組織工学市場：用途別予測・動向分析
第5章. 組織工学市場：地域別予測・動向分析
第6章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Tissue Engineering Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Advancements in stem cell technology & tissue engineering
3.4.1.2. Rise in the number of clinical studies for regenerative medicine and tissue engineering
3.4.1.3. Increasing tissue engineering research funding
3.4.2. Market restraint analysis
3.4.2.1. High cost of product development
3.4.2.2. Ethical concerns related to stem cell research & tissue engineered product
3.4.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
3.5. Tissue Engineering Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. COVID-19 Impact Analysis
Chapter 4. Tissue Engineering Market: Application Estimates & Trend Analysis
4.1. Global Tissue Engineering Market Application Movement Analysis
4.2. Cord blood & Cell banking
4.2.1. Cord blood & Cell banking market estimates and forecast 2018 to 2030 (USD Billion)
4.3. Cancer
4.3.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
4.4. GI/Gynecology
4.4.1. GI/Gynecology therapy market estimates and forecast 2018 to 2030 (USD Billion)
4.5. Dental
4.5.1. Dental market estimates and forecast 2018 to 2030 (USD Billion)
4.6. Skin & Integumentary
4.6.1. Skin & Integumentary market estimates and forecast 2018 to 2030 (USD Billion)
4.7. Urology
4.7.1. Urology market estimates and forecast 2018 to 2030 (USD Billion)
4.8. Orthopedics, Musculoskeletal, & Spine
4.8.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 to 2030 (USD Billion)
4.9. Neurology
4.9.1. Neurology market estimates and forecast 2018 to 2030 (USD Billion)
4.10. Cardiology & Vascular
4.10.1. Cardiology & Vascular market estimates and forecast 2018 to 2030 (USD Billion)
4.11. Others
4.11.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Tissue Engineering Market: Regional Estimates & Trend Analysis
5.1. Tissue Engineering Market: Share By Region, 2022 & 2030
5.2. North America
5.2.1. SWOT Analysis
5.2.2. North America Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.2.3. U.S.
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. U.S. Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.2.4. Canada
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Canada Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3. Europe
5.3.1. SWOT Analysis
5.3.2. Europe Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.3.3. UK
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. UK Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.3.4. Germany
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. Germany Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.5. France
5.3.5.1. Key Country Dynamics
5.3.5.2. Competitive Scenario
5.3.5.3. Regulatory Framework
5.3.5.4. France Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.6. Italy
5.3.6.1. Key Country Dynamics
5.3.6.2. Competitive Scenario
5.3.6.3. Regulatory Framework
5.3.6.4. Italy Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.7. Spain
5.3.7.1. Key Country Dynamics
5.3.7.2. Competitive Scenario
5.3.7.3. Regulatory Framework
5.3.7.4. Spain Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.8. Sweden
5.3.8.1. Key Country Dynamics
5.3.8.2. Competitive Scenario
5.3.8.3. Regulatory Framework
5.3.8.4. Sweden Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.9. Norway
5.3.9.1. Key Country Dynamics
5.3.9.2. Competitive Scenario
5.3.9.3. Regulatory Framework
5.3.9.4. Norway Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.3.10. Denmark
5.3.10.1. Key Country Dynamics
5.3.10.2. Competitive Scenario
5.3.10.3. Regulatory Framework
5.3.10.4. Denmark Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.4. Asia Pacific
5.4.1. SWOT Analysis
5.4.2. Asia Pacific Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.4.3. China
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. China Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.4.4. Japan
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Japan Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.4.5. India
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. India Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.4.6. Australia
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. Australia Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.4.7. Thailand
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Thailand Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.4.8. South Korea
5.4.8.1. Key Country Dynamics
5.4.8.2. Competitive Scenario
5.4.8.3. Regulatory Framework
5.4.8.4. South Korea Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.5. Latin America
5.5.1. SWOT Analysis
5.5.2. Latin America Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.5.3. Brazil
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Brazil Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. Mexico Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.5.5. Argentina
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Argentina Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.6. MEA
5.6.1. SWOT Analysis
5.6.2. MEA Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. South Africa Tissue Engineering Market, 2018 – 2030 (USD Billion)
5.6.4. Saudi Arabia
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. Saudi Arabia Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.6.5. UAE
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. UAE Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
5.6.6. Kuwait
5.6.6.1. Key Country Dynamics
5.6.6.2. Competitive Scenario
5.6.6.3. Regulatory Framework
5.6.6.4. Kuwait Tissue Engineering Testing Market, 2018 – 2030 (USD Billion)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Strategy Mapping
6.3. Key company market share analysis, 2022
6.4. Company Profiles/Listing
6.4.1. Zimmer Biomet Holdings, Inc.
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. AbbVie (Allergan)
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Becton, Dickinson and Company
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. B. Braun
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Integra LifeSciences Corporation
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Organogenesis Holdings Inc.
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Medtronic
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. ACell, Inc.
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Athersys, Inc.
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Tissue Regenix Group plc
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Stryker Corporation
6.4.11.1. Overview
6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. RTI Surgical, Inc.
6.4.12.1. Overview
6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. ReproCell, Inc.
6.4.13.1. Overview
6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
6.4.14. Baxter International, Inc.
6.4.14.1. Overview
6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Billion)
Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 9 Europe tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 10 Europe tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 11 Germany tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 12 UK tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 13 France tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 14 Italy tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 15 Spain tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 16 Sweden tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 17 Norway tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 18 Denmark tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 19 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 20 APAC tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 21 China tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 22 Japan tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 23 India tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 24 Thailand tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 25 South Korea tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 26 Latin America tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 27 Latin America tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 28 Brazil tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 29 Mexico tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Billion)

★調査レポート[組織工学の世界市場2023-2030：市場規模、シェア、動向分析] (コード：GRV23OCT017)販売に関する免責事項を必ずご確認ください。
★調査レポート[組織工学の世界市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 組織工学の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 産業用微生物試験サービスの世界市場2023-2030：市場規模、シェア、動向分析
  • 産業用微生物試験サービスの世界市場2023-2030：市場規模、シェア、動向分析
  • HPV検査＆パップテストの世界市場2023-2030：市場規模、シェア、動向分析
  • HPV検査＆パップテストの世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • 組織診断の世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆